Doxorubicin
40 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
40
Total Reports
10
Deaths Reported
2500.0%
Death Rate
Active Ingredients
Doxorubicin
Administration Routes
UnknownIntravenousOralParenteral
Species Affected
Dog 39
Cat 1
Most Affected Breeds
Retriever - Golden 6
Crossbred Canine/dog 5
Dog (unknown) 4
Retriever - Labrador 4
Boxer (German Boxer) 2
Spaniel (unspecified) 2
Pit Bull 2
Beagle 2
Weimaraner 1
Terrier (unspecified) 1
Most Reported Reactions
Anorexia 10
Diarrhoea 10
Death by euthanasia 9
Lack of efficacy - NOS 9
Weight loss 8
Thrombocytopenia 5
Vomiting 5
Lethargy (see also Central nervous system depression in 'Neurological') 5
Decreased appetite 5
Lethargy (see also Central nervous system depression in Neurological) 5
Neutropenia 4
Urinary incontinence 3
Outcome Breakdown
Outcome Unknown
15 (37.5%)
Ongoing
12 (30.0%)
Euthanized
8 (20.0%)
Recovered/Normal
3 (7.5%)
Died
2 (5.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.